作为TAAR1的激动剂,ulotaront以状态依赖的方式调节状体和海马体的谷氨酸酸功能
Sung M Yang1, Ayan Ghoshal1, Jeffrey M Hubbard2
1Sumitomo Pharma America, Inc., Marlborough, MA, USA.
概括
微氨基关联受体1 (TAAR1) 激动剂,如ulotaront,通过调节谷氨酸功能,对精神分裂症有很大的希望. 这些化合物调节突触传输和神经元发射,潜在地使乱中涉及的大脑回路正常化.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 精神分裂症的病理生理学涉及失调的多巴胺和谷氨酸信号传递,特别是在条体和海马体.
- 微氨基关联受体1 (TAAR1) 激素是一种新的精神分裂症治疗策略,在III期试验中使用了ulotaront.
- 对TAAR1激动剂对谷氨基酶功能和神经刺激-抑制平衡的确切影响仍然不完全理解.
研究的目的:
- 为了研究ULOTARONT,TAAR1激动剂对小鼠条体和海马体的谷氨酸功能的影响.
- 探索TAAR1激动剂在调节精神分裂症激发抑制平衡方面的潜力.
主要方法:
- 在小鼠大脑切片上进行了电生理学记录.
- 评估了ulotaront和另一种TAAR1激动剂 (RO5166017) 对自发和唤起的谷氨酸突触传播的影响.
- 检查了神经元发射和激发-抑制平衡在条纹体中的调节.
主要成果:
- 乌罗塔龙降低了自发的谷氨酸转移和神经元在条形体和海马体中的激发.
- 在这两个区域,由ulotaront增强了电气唤起的刺激传输,这表明了依赖状态的调制.
- 乌洛塔龙特选择性调节的谷氨基基,而不是GABAergic,在条形体中发生自发事件,影响激发-抑制平衡.
结论:
- 乌罗塔龙和TAAR1激动剂可以以状态依赖的方式调节谷氨酸性神经传递.
- 这些发现支持对超越多巴胺调节的TAAR1激动剂的更广泛的机制理解.
- TAAR1激动剂可以通过解决精神分裂症中多巴胺和谷氨酸异常来提供独特的治疗方法.
相关概念视频
01:29Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
01:25Adrenergic Agonists: Indirect-Acting Agents
1.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.6K
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
310
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
310
01:14Antiepileptic Drugs: Glutamate Antagonists
376
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
376
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.1K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.1K